Electronic pillboxes (MEMS) to assess the relationship between medication adherence and blood pressure control in primary care

References

• Major outcomes in high–risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981–97.
   PubMed Web of Science ®Google Scholar
• Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10–17
   PubMed Web of Science ®Google Scholar
• Rudd P. Clinicians and patients with hypertension: Unsettled issues about compliance. Am Heart J 1995; 30: 572–9
   Web of Science ®Google Scholar
• Briggs WA, Lowenthal DT, Cirksena WJ, Price WE, Gibson TP, Flamenbaum W. Propranolol in hypertensive dialysis patients: Efficacy and compliance. Clin Pharmacol Ther 1975; 18: 606–12
   PubMedGoogle Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67–74
   PubMed Web of Science ®Google Scholar
• Podell RN, Kent D, Keller K. Patient psychological defenses and physician response in the long-term treatment of hypertension. J Fam Pract 1976; 3: 145–9
   PubMedGoogle Scholar
• Schroeder K, Fahey T, Hollinghurst S, Peters TJ. Nurse-led adherence support in hypertension: A randomized controlled trial. Fam Pract 2005; 22: 144–51
   PubMed Web of Science ®Google Scholar
• Wetzels GE, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: A systematic review. J Hypertens 2004; 22: 1849–55
   PubMed Web of Science ®Google Scholar
• Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ. Relationship between medication adherence and blood pressure in primary care: Prospective study. J Hum Hypertens 2006; 20: 625–7
   PubMedGoogle Scholar
• 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011–53.
   PubMed Web of Science ®Google Scholar
• Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634–40
   PubMed Web of Science ®Google Scholar
• Sabeté E, et al. Adherence to long-term therapy: Evidence for action. World Health Organization, GenevaSwitzerland 2003
   Google Scholar
• Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957–63
   PubMed Web of Science ®Google Scholar
• Hosie J, Wiklund I. Managing hypertension in general practice: Can we do better?. J Hum Hypertens 1995; 9: S15–18
   PubMed Web of Science ®Google Scholar
• Steinman MA, Fischer MA, Shlipak MG, et al. Clinician awareness of adherence to hypertension guidelines. Am J Med 2004; 117: 747–54
   PubMed Web of Science ®Google Scholar
• Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001; 135: 825–34
   PubMed Web of Science ®Google Scholar
• Cranney M, Warren E, Barton S, Gardner K, Walley T. Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract 2001; 18: 359–63
   PubMed Web of Science ®Google Scholar
• Hedblad B, Nerbrand C, Ekesbo R, et al. High blood pressure despite treatment: Results from a cross-sectional primary healthcare-based study in southern Sweden. Scand J Prim Health Care 2006; 24: 224–30
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: Factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594–9
   PubMed Web of Science ®Google Scholar
• Bertholet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M. Why objective monitoring of compliance is important in the management of hypertension. J Clin Hypertens (Greenwich) 2000; 2: 258–62
   PubMedGoogle Scholar
• Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions. J Hypertens 2001; 19: 335–41
   PubMed Web of Science ®Google Scholar
• Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: A prospective case-control study. BMJ 2001; 323: 142–6
   PubMedGoogle Scholar
• Mallion JM, Dutrey-Dupagne C, Vaur L, et al. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens 1996; 14: 137–44
   PubMed Web of Science ®Google Scholar
• Vaur L, Vaisse B, Genes N, Elkik F, Legrand C, Poggi L. Use of electronic pill boxes to assess risk of poor treatment compliance: Results of a large-scale trial. Am J Hypertens 1999; 12: 374–80
   PubMedGoogle Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23: 1296–310
   PubMed Web of Science ®Google Scholar
• Leenen FH, Wilson TW, Bolli P, et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: A randomized clinical trial using electronic monitoring. Can J Cardiol 1997; 13: 914–20
   PubMed Web of Science ®Google Scholar
• Haynes, RB, McDonald, H, Garg, AX, Montague, P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002; CD000011.
   PubMedGoogle Scholar
• Wickstrom G, Bendix T. The “Hawthorne effect”—What did the original Hawthorne studies actually show?. Scand J Work Environ Health 2000; 26: 363–7
   PubMed Web of Science ®Google Scholar
• McKenney JM, Munroe WP, Wright JT, Jr. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992; 32: 277–83
   PubMed Web of Science ®Google Scholar
• Mengden T, Binswanger B, Spuhler T, Weisser B, Vetter W. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 1993; 11: 1403–11
   PubMed Web of Science ®Google Scholar
• Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150: 1509–10
   PubMed Web of Science ®Google Scholar
• Primatesta P, Poulter NR. Improvement in hypertension management in England: Results from the Health Survey for England 2006. J Hypertens 2003; 24: 1193–200
   Google Scholar